Trial intelligence / Profile preview

Auxora in Severe COVID-19 Pneumonia (CARDEA)

NCT04345614Phase 2Completed

Sponsor
CalciMedica
Start
Apr 2020
Primary completion
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Auxora in COVID-19 pneumonia, sponsored by CalciMedica. Started Apr 2020; status: completed.

02

Drugs

Auxora
03

Conditions

COVID-19 pneumonia

Beyond the preview

Go deeper on NCT04345614.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04345614.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call